Evoke Pharma Inc

NASDAQ:EVOK   10:19:50 AM EDT
0.59
+0.01 (+0.87%)
Earnings Announcements

Evoke Pharma Reports Q3 2021 Financial Results

Published: 11/10/2021 22:29 GMT
Evoke Pharma Inc (EVOK) - Evoke Pharma Reports Third Quarter 2021 Financial Results.
Q3 Loss per Share $0.06.
Revenue is expected to be $0.51 Million
Adjusted EPS is expected to be -$0.08

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.